SOMERSET, N.J., Feb. 22, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc.
(Nasdaq:VTIV), a leading provider of commercialization solutions to the
global healthcare industries, announced that it has appointed former
Pfizer executive Eric Sirota as President of inVentiv Commercial
Services.

Mr. Sirota joins inVentiv following a successful 20-year career at
Pfizer where he held a progressive series of senior-level roles, most
recently serving as Vice President of U.S. Marketing, Commercial
Strategy and Innovation, and Regional Sales within the Powers business
unit.

While at Pfizer, Mr. Sirota provided commercial leadership on products
in 12 major therapeutic categories in both U.S. and global markets.
Over a four year period beginning in 2003, he successively led the
marketing for four of the five Pfizer U.S. therapeutic clusters, with
sales ranging from $2.3 to $5.2 billion. In addition, Mr. Sirota was
the first U.S. business unit Vice President at Pfizer to take on a
unified role leading both marketing and sales. He also created a
Commercial Strategy group within the Powers business unit to spearhead
business and sales innovation, and led the development and execution of
the first Pfizer "New Commercial Model" pilot designed to test
different approaches to enhance customer engagement.

As President of inVentiv Commercial Services, Mr. Sirota will oversee
the Selling Solutions and Advance Insights divisions. His primary role
will be to lead the organization in developing new strategies to
address the critical need in the pharmaceutical industry for integrated
analytics, sales and marketing solutions that enhance brand revenue,
drive efficiencies and lower costs. Mr. Sirota will report to Blane
Walter, Chief Executive Officer of inVentiv Health

"Eric's exceptional career at Pfizer makes him an ideal person to lead
our Commercial segment. Having recently been on the 'client-side,' he
brings insights we can leverage to enhance our offerings and drive new
connections with senior-level pharmaceutical executives," said Mr.
Walter. "Eric's leadership also will help us drive greater use of
outsourcing among our healthcare clients, and strengthen our position
as the market leader in outsourced commercial solutions. We are
thrilled to add him to our leadership team."

"I am deeply impressed by inVentiv's breadth of capabilities and focus
on developing innovative outsourcing solutions to help healthcare
companies commercialize products more efficiently and effectively.
Outsourcing is a growing movement in the pharmaceutical industry, and
inVentiv is well positioned to benefit from that trend. I'm excited by
the opportunity to work with this team and develop new strategies to
meet the needs of our clients," said Mr. Sirota.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global
healthcare leader that provides dynamic solutions to deliver customer
and patient success. inVentiv delivers its customized clinical, sales,
marketing and communications solutions through its four core business
segments: inVentiv Clinical, inVentiv Communications, inVentiv
Commercial, and inVentiv Patient Outcomes. inVentiv Health's client
roster is comprised of more than 350 leading pharmaceutical, biotech,
life sciences and healthcare payor companies, including all top 20
global pharmaceutical manufacturers. For more information, visit
www.inventivhealth.com.

The inVentiv Health, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=4942

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks that may
cause inVentiv Health's performance to differ materially. Such risks
include, without limitation: changes in trends in the pharmaceutical
industry or in pharmaceutical outsourcing; our ability to compete
successfully with other services in the market; our ability to maintain
large client contracts or to enter into new contracts; and, our ability
to operate successfully in new lines of business. Readers of this press
release are referred to documents filed from time to time by inVentiv
Health, Inc. with the Securities and Exchange Commission for further
discussion of these and other factors.


CONTACT:  inVentiv Health, Inc.
          Investors/Corporate:
          David Bassin, CFO
            (732) 537-4804
            investor@inventivhealth.com
          Media:
          Marcia Frederick
            (614) 543-6281
            mfrederick@inventivhealth.com